{"id":3681,"date":"2018-04-20T10:00:00","date_gmt":"2018-04-20T01:00:00","guid":{"rendered":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/?p=3681"},"modified":"2025-12-09T13:26:11","modified_gmt":"2025-12-09T04:26:11","slug":"the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2","status":"publish","type":"post","link":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/","title":{"rendered":"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2"},"content":{"rendered":"\r\n

Pao-Li Wang1)*, Yoichi Tachi2)*, Kazuya Masuno1), Nobutaka Okusa3) and Yasuhiro Imamura4)
1) Department of Innovation in Dental Education, Osaka Dental University, Osaka, Japan
2) Laboratory of Nutritional Physiology, Tokyo Kasei University, Tokyo, Japan
3) Department of Forensic Dentistry, Osaka Dental University, Osaka, Japan
4) Department of Dental Pharmacology, Matsumoto Dental University, Shiojiri, Japan
(Accepted for publication, April 20, 2018)<\/p>\r\n\r\n\r\n\r\n

Abstract<\/h3>\r\n\r\n\r\n\r\n

Ozone is currently being considered as a potential oral antiseptic agent because it is highly antimicrobial and does not induce microbial resistance. In this study, we demonstrated that an optimal dosage of ozone gel enhanced the proliferation, type 1 collagen production, and alkaline phosphatase (ALP) secretion of Saos-2 cells in vitro. Proliferation of Saos-2 cells was assessed by MTT and DNA synthesis assays. Type 1 collagen production and ALP secretion were evaluated using enzymelinked immunosorbent assay (ELISA) and ALP assays. The cells were treated with\/without 0.05, 0.5, 5 ppm ozone gel for 24 h. Ozone gel (0.5 ppm) signifi cantly induced the proliferation of Saos-2 cells. At this concentration, ozone gel enhanced type 1 collagen production and ALP secretion. The results indicated that ozone gel controls the cellular metabolism of osteoblasts, resulting in the secretion of early bone-related biomarkers.<\/p>\r\n\r\n\r\n\r\n

<\/p>\r\n\r\n\r\n\r\n

Key words<\/h3>\r\n\r\n\r\n\r\n

Ozone gel, ALP, Collagen, Osteoblast, Saos-2 cells<\/p>\r\n\r\n\r\n\r\n

Introduction<\/h3>\r\n\r\n\r\n\r\n

Ozone is currently being considered in dentistry as a potential alternative oral antiseptic agent. Its strong antimicrobial eff ect without the development of drug resistance has been previously noted in water purification and food preservation techniques1-3). In dentistry, ozone has been used either in gaseous or aqueous forms for the elimination of pathogens causing caries, in the disinfection of root canals, and as a rinse for avulsed teeth4-8). However, ozone has an unpleasant smell and a short half-life of approximately 40 min9). Ozone also has low water solubility, and therefore, aqueous ozone formulations provide no longterm sterilization effect. On the contrary, ozone gel, which consists of a glycerin solution containing ozone, has a long-term sterilization eff ect. The advantages of ozone gel include a 6-month-long sterilization eff ect, the lack of an unpleasant smell, and no development of bacterial strains manifesting ozone-resistance. Previously, we reported the safety evaluation of ozone for the skin and eye, as well as its antimicrobial eff ects and role in hemostasis using ozone gel10-12). In addition, a number of reports have shown that ozone can ameliorate periodontal diseases13-15). However, the effects of ozone on the functions of cells involved in periodontal disease are yet to be elucidated16-19). Recently, we reported the effects of ozone gel on the production of inflammatory cytokines and type I collagen in human gingival fi broblasts (HGFs) in vitro, and attempted to elucidate the mechanism of action of ozone on periodontal disease20). In this study, we examined effects of ozone gel on type 1 collagen production and alkaline phosphatase (ALP) secretion in the human osteosarcoma cell line Saos-2.<\/p>\r\n\r\n\r\n\r\n

Materials and Methods<\/h2>\r\n\r\n\r\n\r\n

Cell cultures<\/h3>\r\n\r\n\r\n\r\n

Saos-2 cells (RIKEN BRC Cell Bank, Tokyo, Japan) were cultured in Dulbecco\u2019s modified Eagle\u2019s medium (DMEM, Nissui pharmaceutical Co. Ltd., Tokyo, Japan) with 10% fetal bovine serum (FBS), 100 units\/ml penicillin G, and 100 \u03bcg\/ml streptomycin at 37\u00b0C in a 5% CO2 and 95% air humidifi ed incubator.<\/p>\r\n\r\n\r\n\r\n

DNA synthesis and MTT assays<\/h3>\r\n\r\n\r\n\r\n

For DNA synthesis, Saos-2 cells (1×104 ) were cultured in DMEM containing 0.5% FBS (0.5% DMEM) for 24 h. The cells were cultured with the ozone gel (VMC Co. Ltd. Tokyo, Japan) or at 0.05, 0.5, and 5 ppm for 2 min, and the culture medium was removed. Then, the cells were washed with 0.5% DMEM and were cultured with 0.5% DMEM containing bromodeoxy uridine (BrdU) for 24 h. The level of DNA synthesis was determined by measuring BrdU-incorporation using the BrdU cell proliferation assay kit (Millipore Tokyo, Japan).<\/p>\r\n\r\n\r\n\r\n

For MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma- Aldrich) assay, cells were cultured with the ozone gel at 0.05, 0.5, and 5 ppm in DMEM containing 10% FBS (10% DMEM) for 2 min, and the culture medium was removed. After washing with 10% DMEM, the cells were cultured with 10% DMEM for 24 h. The subsequent procedures were performed as described elsewhere21).<\/p>\r\n\r\n\r\n\r\n

Enzyme-linked immunosorbent assays (ELISA)<\/h3>\r\n\r\n\r\n\r\n

For collagen production, Saos-2 cells (1×104 ) were cultured in DMEM containing 1% FBS (1% DMEM) with the ozone gel (0.5 ppm) for 2 min. The cells were washed and cultured with 1% DMEM. Levels of type I collagen in the media were measured using the biotinylated antitype I collagen antibody (0.2 \u03bcg\/ml, Rockland). ELISA was performed as described in the user manual of CytoSet kits (Biosource, Tokyo, Japan)22). The cells for collagen production were lysed with 0.5% TritonX-100, and the protein concentration of the cell lysates was measured using a bicinchoninic acid (BCA) protein assay kit (Pierce, Tokyo, Japan). Collagen production was normalized to the protein content of the cell lysates.<\/p>\r\n\r\n\r\n\r\n

ALP activity<\/h3>\r\n\r\n\r\n\r\n

Saos-2 cells (1×104 ) were cultured with the ozone gel (0.5 ppm) for 2 min, and the culture medium was removed. The cells were washed with 0.5% DMEM and cultured with 10% DMEM for 24 h. The cells were lysed with 0.05% TritonX-100 and ALP activity of the lysates was measured using a LabAssay ALP kit (Wako Pure Chemicals Industries, Ltd., Osaka, Japan). The protein concentrations of the cell lysates were also measured using a BCA protein assay kit. ALP activity was normalized to the protein content of the cell lysates.<\/p>\r\n\r\n\r\n\r\n

Statistical analysis<\/h3>\r\n\r\n\r\n\r\n

Quantitative data were statistically analyzed using either one-way analysis of variance (ANOVA) followed by Tukey\u2019s test (DNA synthesis and MTT assays) or Student\u2019s t-test (measurement of ALP activity and ELISA for collagen production) using the StatMate software (ATMS). Diff erences were considered to be signifi cant at p < 0.05.<\/p>\r\n\r\n\r\n\r\n

J Hard Tissue Biology Vol. 27(3):195-198, 2018 27(3):195-198, 2018<\/h3>\r\n\r\n\r\n\r\n
\"\"\r\n
Figure 1. Effect of ozone gel on the proliferation of Saos-2.<\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n

(a) MTT assay. (b) DNA synthesis assay. Saos-2 seeded at a volume of 3.1 \u00d7 104\/ cm2 were exposed to media, which contain 0.05, 0.5, or 5 ppm ozone gel (designated as +, ++, and +++) for 24 h. All data were compared with those for cells treated with control medium without ozone gel. Data have been provided as mean \u00b1 S.D. (n = 3). **P < 0.01 and ***P < 0.001, analyzed with ANOVA with a Dunnett\u2019s test (vs. none).<\/p>\r\n\r\n\r\n\r\n

\"\"\r\n
Figure 2. Collagen type-1 production of Saos-2 treated with the ozone gel.<\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n

Saos-2 cells were seeded at a volume of 3.1 \u00d7 104\/cm2 and were exposed to media containing 0.5 ppm Ozone gel for 24 h. Data have been provided as mean \u00b1 standard deviation (n = 3). ***P < 0.001, analyzed with Student\u2019s t-test (vs. none).<\/p>\r\n\r\n\r\n\r\n

\"\"\r\n
Figure 3. ALP secretion of Saos-2 treated with ozone gel.<\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n

Saos-2 was seeded at 3.1 \u00d7 104\/cm2 condition, and was exposed to media containing 0.5 ppm ozone gel for 24 h. Data have been provided as mean \u00b1 standard deviation (n = 3). **P < 0.01, analyzed with Student\u2019s t-test (vs. none).<\/p>\r\n\r\n\r\n\r\n

Results<\/h2>\r\n\r\n\r\n\r\n

Eff ect of ozone gel on proliferation of Saos-2 cells<\/h3>\r\n\r\n\r\n\r\n

After 24 h of incubation, the ozone gel treatment increased Saos-2 proliferation in a dose-dependent manner (Fig. 1). Ozone gel at 0.5 ppm signifi cantly induced cell growth compared to the other concentrations, whereas no obvious change was observed with 0.5 ppm ozone gel treatment. Similar to the results of the MTT assay, 0.5 ppm ozone gel eff ectively elevated DNA synthesis in Saos-2 cells, indicating the optimal concentration of ozone gel required for facilitating the proliferation of Saos-2 cells.<\/p>\r\n\r\n\r\n\r\n

Eff ect of ozone gel on type 1 collagen production and ALP secretion by Saos-2 cells<\/h3>\r\n\r\n\r\n\r\n

Ozone gel at 0.5 ppm significantly induced cell growth. This, considering the results of the proliferation assays, we further evaluated the effect of ozone gel on collagen 1 production and ALP secretion from Saos-2 cells using 0.5 ppm ozone gel. Addition of ozone gel in the media eff ectively increased type 1 collagen production (Fig. 2) and ALP secretion (Fig. 3) from Saos-2 cells compared to that without ozone gel treatment.<\/p>\r\n\r\n\r\n\r\n

Discussion<\/h3>\r\n\r\n\r\n\r\n

The eff ect of ozone gel on bone matrix production by osteoblasts is unclear. The present study showed that while high concentrations of the ozone gel decreased the cell viability index, low concentrations of the gel enhanced cell proliferation. Furthermore, 0.5 ppm ozone gel promoted the secretion of type 1 collagen and ALP, which are highly related to bone formation.<\/p>\r\n\r\n\r\n\r\n

Previously, Oda et al. reported that 10 ppm ozone gel suppresses the proliferation of human gingival fibroblasts23). The present study showed that while cell proliferation was signifi cantly suppressed at high concentrations (5 ppm) of ozone gel, 0.5 ppm ozone gel promoted cell proliferation. In a study on non-gel forms of ozone, Tsujiue et al. reported that ozone water dissolved in phosphate-buff ered saline (PBS) induced cell damage at 3 ppm as visualized by hematoxylin and eosin staining24). A study using alveolar macrophages reported that 0.5 ppm ozone gas causes cellular damage to the monocyte strain THP-125). Ozone gel has the advantage of providing sustained release of ozone, which is contained within glycerin20). On the basis of these observations, we conclude that the ozone gel exhibits pharmacological effects without cytotoxicity at the available low concentrations and by further lowering the effective concentration via its sustained-release eff ect; however, it shows Holmins eff ect, i.e., cytotoxicity above a certain concentration.<\/p>\r\n\r\n\r\n\r\n

Type 1 collagen and ALP are widely known as markers secreted in the early phases of bone formation20). In this study, these initial-phase bone matrix markers were secreted at an optimum concentration of the ozone gel. Currently, moderate levels of active oxygen species are thought to act as an intracellular signaling substance. Reactive oxygen species control intracellular signal transduction by chemically modifying proteins, nucleic acids, and lipids. Among these, participation of stress adaptation response by the Keep 1\/Nrf 2 pathway is being actively researched. However, Nrf2 is known to negatively regulate the differentiation of osteoblasts. Therefore, it is highly likely that type 1 collagen secretion and increased expression of ALP observed in this study occurred via routes that did not involve Nrf2. Unfortunately, this study did not investigate the mechanism underlying the upregulation of these early bone matrix markers. Previous reports have identified that oxygen ozone therapy promotes the production of growth factors such as VEGF27). In addition, ozone gas is known to promote the production of FGF and other related cytokines28). VEGF enhances ALP expression in the mouse osteoblast cell line MC3T3-129). Thus, it is possible that bone matrix secretion may have been indirectly promoted via the secretion of these growth factors.<\/p>\r\n\r\n\r\n\r\n

Our study demonstrates that 0.5 ppm ozone gel increases the secretion of osteoblast matrix without showing any signs of cell damage. Our previous reports have elucidated that the same concentration of ozone gel promotes secretion of collagen matrix and suppresses LPS-induced IL-6 and IL-8 expression without exhibiting cytotoxicity to human gingival fi broblasts20). Although it is diffi cult to directly link the results of in vitro and in vivo experiments, our results suggest that ozone gas, ozone water, ozone-olive oil30), and ozone gel may be used as therapeutic agents for periodontal disease. However, such applications will require detailed evaluation, such as assessment of biological safety using animal models and functional studies on its long-term eff ects in terms of cellular damage.<\/p>\r\n\r\n\r\n\r\n

References<\/h3>\r\n\r\n\r\n\r\n

1. Paraskeva P and Graham NJ. Ozonation of municipal wastewater effl uents. Water Environ. Res 74: 569-581, 2002<\/em>
2. Restaino L, Frampton EW, Hemphill JB and Palnikar P. Effi cacy of ozonated water against various food-related microorganisms. Appl Environ Microbiol 61: 3471-3475, 1995<\/em>
3. Unal R, Kim JG and Yousef AE. Inactivation of Escherichia coli O157: H7, Listeria monocytogenes, and Lactobacillus leichmannii by combinations of ozone and pulsed electric fi eld. J Food Prot 64: 777-782, 2001<\/em>
4. Baysan A and Lynch E. Eff ect of ozone on the oral microbiota and clinical severity of primary root caries. Am Dent 17: 56-60, 2004<\/em>
5. Ebensberger U, Pohl Y and Filippi A. PCNA expression of cementoblasts and fibroblasts on the root surface after extraoral rinsing for decontamination. Dent Traumatol 18: 262-266, 2002<\/em>
6. Huth KC, Paschos E, Brand K and Hickel R. Eff ect of ozone on noncavitated fissure carious lesions in permanent molars. A controlled prospective clinical study. Am J Dent 18: 223-228, 2005<\/em>
7. Kumar M, Haldia A, Gupta R and Meena D. Ozone therapy in dentistry- a review. J Sci Tech 1: 181-185, 2015<\/em>
8. Nogales CG, Ferrari PH, Kantorovich EO and Lage-Marques J. Ozone therapy in medicine and dentistry. J Contemp Dent Pract 9:75-84, 2008<\/em>
9. Bocci V. Mechanism of action on ozone. In: Oxygen-ozone therapy.A critical evaluation, ed by Bocci V, Maruzen Publishing, Inc.,Tokyo, 2012, pp 17-25. (in Japanese)<\/em>
10. Wang PL, Shiota G and Shiba A. Safety evaluation of ozone gel for skin and eye on animal experiments. J Hard Tissue Biol 20: 313-318, 2011<\/em>
11. Fukui T, Masuno K, Makita Y, Fujiwara S and Shiota G.Antimicrobial effects of ozone gel against periodontal bacteria. J Hard Tissue Biol 23: 445-448, 2014<\/em>
12. Sakai D, Makita Y, Masuno K, Fujiwara S and Okazaki J. Local hemostatic eff ect of aqueous ozone in cutting wound surface. J
Hard Tissue Biol 23: 245-248, 2014<\/em>
13. Srikanth A, Sathish M and Sri Harsha AV. Application of ozone in the treatment of periodontal disease. J Pharm Bioallied Sci 5: S89-94,2013<\/em>
14. Saini R. Ozone therapy in dentistry: A strategic review. J Nat Sci Biol Med 2: 151-153, 2011<\/em>
15. Arpita R, Swetha JL, Babu MR and Sudhir R. Recent trends in nonsurgical periodontal care for the general dentist-a review. Bangl J
Dent Res Edu 4: 78-82, 2014<\/em>
16. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H and Floros J. The eff ect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production. Environ Health Perspect 110: 79-84, 2002<\/em>
17. Li Z, Tighe RM, Feng F, Ledford JG and Hollingsworth JW. Genes of innate immunity and the biological response to inhaled ozone. J
Biochem Mol Toxicol 27: 3-16, 2013<\/em>
18. Huang W, Wang G, Phelps DS, Al-Mondhiry H and Floros J. Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: eff ect of ozone-induced SP-A oxidation. Am J Physiol-Lung Cell Mol Physiol 286: 546-553, 2004<\/em>
19. Mikerov AN, Umstead TM, Gan X, Huang W, Guo X, Wang G,Phelps DS and Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol-Lung Cell Mol Physiol 294: 121-130, 2008<\/em>
20. Makita Y, Imamura Y, Masuno K, Fujiwara S, Shiota G, Shiba A and Wang PL. The Eff ect of Ozone on Collagen Type-1 and Infl amatory Cytokine Production in Human Gingival Fibroblasts. Dentistry 5:339.doi:10.4172\/2161-1122. 1000339, 2015<\/em>
21. Imamura Y, Fujigaki Y, Oomori Y, Usui S and Wang PL. Cooperation of salivary protein histatin 3 with heat shock cognate protein 70 relative to the G1\/S transition in human gingival fi broblasts. J Biol Chem 284: 14316-14325, 2009<\/em>
22. Imamura Y and Wang PL. Salivary histatin 3 inhibits heat shock cognate protein 70-mediated inflammatory cytokine production through toll-like receptors in human gingival fi broblasts. J Infl amm (Lond) 11: 4, 2014<\/em>
23. Oda H, Maruyama, K, Tsubokawa M, Sioda G, Kamoi H, Nagahiro K and Sato S. Eff ect of ozone gel on oral pathogens and human gingiva and periodontal ligament fi broblasts. Jpn J Conserv Den 57: 369-376, 2014<\/em>
24. Tsujigami H. Sttudy of cytotoxic and bactericidal eff ects of ozonized water against periodontium-derived cells and periodontopathic bacteria. J Jpn Assoc Periodontol 44: 46-54, 2002<\/em>
25. Klestadt D1, Laval-Gilly P and Falla J. Ozone-mediated cytotoxicity after short-term exposure and its relation to the production of cellular metabolites (NO, H2O2). Cell Biol Toxicol 18: 259-269, 2002<\/em>
26. Miron RJ and Zhang YF. Osteoinduction: a review of old concepts with new standards. J Dent Res 91: 736-744, 2012<\/em>
27. Zhang J, Guan M, Xie C, Luo X, Zhang Q and Xue Y. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxid Med Cell Longev. 273475. doi: 10.1155\/2014\/273475, 2014<\/em>
28. Rei L, mart\u00ednez-s\u00e1nchez G, perez-davison G and Sirito M. Role of ozone\/oxygen in fi broblast growth factor activation. Discovering the Facts Int J Ozone Therapy 9: 55-58, 2010<\/em>
29. Tan YY, Yang YQ, Chai L, Wong RW and Rabie AB. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. Orthod Craniofac Res 13: 223-228, 2010<\/em>
30. Srikanth A1, Sathish M and Sri Harsha AV. Application of ozone in the treatment of periodontal disease.J Phar Bioallied Sci 5: 89-94,2013<\/em><\/p>\r\n","protected":false},"excerpt":{"rendered":"

Pao-Li Wang1)*, Yoichi Tachi2)*, Kazuya Masuno1), Nobutaka Okusa3) and Yasuhiro Imamura4)1) Department of Innovation in Dental Education, Osaka Dental University, Osaka, Japan2) Laboratory of Nutritional Physiology, Tokyo Kasei University, Tokyo, Japan3) Department of Forensic Dentistry, Osaka Dental University, Osaka, Japan4) Department of Dental Pharmacology, Matsumoto Dental University, Shiojiri, Japan(Accepted for publication, April 20, 2018) Abstract Ozone is currently being considered […]<\/p>\n","protected":false},"author":1,"featured_media":2680,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130],"tags":[],"class_list":["post-3681","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-academic-paper-en"],"yoast_head":"\nThe Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2 - Mediplus Pharma, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2 - Mediplus Pharma, Inc.\" \/>\n<meta property=\"og:description\" content=\"Pao-Li Wang1)*, Yoichi Tachi2)*, Kazuya Masuno1), Nobutaka Okusa3) and Yasuhiro Imamura4)1) Department of Innovation in Dental Education, Osaka Dental University, Osaka, Japan2) Laboratory of Nutritional Physiology, Tokyo Kasei University, Tokyo, Japan3) Department of Forensic Dentistry, Osaka Dental University, Osaka, Japan4) Department of Dental Pharmacology, Matsumoto Dental University, Shiojiri, Japan(Accepted for publication, April 20, 2018) Abstract Ozone is currently being considered […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Mediplus Pharma, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-20T01:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-09T04:26:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mediplus Pharma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/\",\"name\":\"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2 - Mediplus Pharma, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg\",\"datePublished\":\"2018-04-20T01:00:00+00:00\",\"dateModified\":\"2025-12-09T04:26:11+00:00\",\"author\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#primaryimage\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg\",\"contentUrl\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg\",\"width\":640,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#website\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/\",\"name\":\"Mediplus Pharma, Inc.\",\"description\":\"Passion for Sustainable Future By Novel Glycerin Compounds. Mediplus pharma, Inc.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e\",\"name\":\"Mediplus Pharma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g\",\"caption\":\"Mediplus Pharma\"},\"sameAs\":[\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\"],\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/author\/mpp-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2 - Mediplus Pharma, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/","og_locale":"en_US","og_type":"article","og_title":"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2 - Mediplus Pharma, Inc.","og_description":"Pao-Li Wang1)*, Yoichi Tachi2)*, Kazuya Masuno1), Nobutaka Okusa3) and Yasuhiro Imamura4)1) Department of Innovation in Dental Education, Osaka Dental University, Osaka, Japan2) Laboratory of Nutritional Physiology, Tokyo Kasei University, Tokyo, Japan3) Department of Forensic Dentistry, Osaka Dental University, Osaka, Japan4) Department of Dental Pharmacology, Matsumoto Dental University, Shiojiri, Japan(Accepted for publication, April 20, 2018) Abstract Ozone is currently being considered […]","og_url":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/","og_site_name":"Mediplus Pharma, Inc.","article_published_time":"2018-04-20T01:00:00+00:00","article_modified_time":"2025-12-09T04:26:11+00:00","og_image":[{"width":640,"height":480,"url":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg","type":"image\/jpeg"}],"author":"Mediplus Pharma","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/","url":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/","name":"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2 - Mediplus Pharma, Inc.","isPartOf":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#primaryimage"},"image":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg","datePublished":"2018-04-20T01:00:00+00:00","dateModified":"2025-12-09T04:26:11+00:00","author":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e"},"breadcrumb":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#primaryimage","url":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg","contentUrl":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2023\/01\/ef8717074b149dde763e519271a49f85.jpg","width":640,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/the-eff-ect-of-ozone-gel-on-bone-matrix-production-by-human-osteosarcoma-cell-line-saos-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.mediplus-pharma.co.jp\/en\/home\/"},{"@type":"ListItem","position":2,"name":"The Effect of Ozone Gel on Bone Matrix Production by Human Osteosarcoma Cell Line Saos-2"}]},{"@type":"WebSite","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#website","url":"https:\/\/www.mediplus-pharma.co.jp\/en\/","name":"Mediplus Pharma, Inc.","description":"Passion for Sustainable Future By Novel Glycerin Compounds. Mediplus pharma, Inc.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mediplus-pharma.co.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e","name":"Mediplus Pharma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g","caption":"Mediplus Pharma"},"sameAs":["https:\/\/www.mediplus-pharma.co.jp\/_wordpress"],"url":"https:\/\/www.mediplus-pharma.co.jp\/en\/author\/mpp-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3681"}],"collection":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/comments?post=3681"}],"version-history":[{"count":5,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3681\/revisions"}],"predecessor-version":[{"id":5949,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3681\/revisions\/5949"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/media\/2680"}],"wp:attachment":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/media?parent=3681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/categories?post=3681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/tags?post=3681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}